Issue
Alert me when new journal issues are available via or via
Editorial Board page IFC Full-Text PDF (97 KB)
Contents pages iii-iv Full-Text PDF (88 KB)
Treatment of psoriasis: a journey from empiricism to evidence Michael P. Schön pages 417-418 Full Text | Full-Text PDF (72 KB)
Options for the treatment of psoriasis: a multifactorial approach Peter C.M. van de Kerkhof pages 419-423 Abstract | Full Text | Full-Text PDF (133 KB)
Economic considerations in psoriasis management Marc Alexander Radtke, Matthias Augustin pages 424-431 Abstract | Full Text | Full-Text PDF (148 KB)
Topical treatments in psoriasis: today and tomorrow Jan D. Bos, Phyllis I. Spuls pages 432-437 Abstract | Full Text | Full-Text PDF (123 KB)
Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine Richard B. Warren, Christopher E.M. Griffiths pages 438-447 Abstract | Full Text | Full-Text PDF (271 KB)
Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas Gottfried Wozel pages 448-459 Abstract | Full Text | Full-Text PDF (967 KB)
Psoriatic arthritis: therapeutic principles Martin Feuchtenberger, Stefan Kleinert, Hans-Peter Tony, Christian Kneitz pages 460-463 Abstract | Full Text | Full-Text PDF (100 KB)
Phototherapy and photochemotherapy Lars Alexander Schneider, Ralf Hinrichs, Karin Scharffetter-Kochanek pages 464-476 Abstract | Full Text | Full-Text PDF (422 KB)
Climatotherapy of psoriasis Jana Kazandjieva, Ivan Grozdev, Razvigor Darlenski, Nikolai Tsankov pages 477-485 Abstract | Full Text | Full-Text PDF (184 KB)
Tumor necrosis factor antagonists in the therapy of psoriasis Rotraut Mössner, Michael P. Schön, Kristian Reich pages 486-502 Abstract | Full Text | Full-Text PDF (595 KB)
Alefacept in the treatment of psoriasis Hideaki Sugiyama, Thomas S. McCormick, Kevin D. Cooper, Neil J. Korman pages 503-508 Abstract | Full Text | Full-Text PDF (313 KB)
Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety Michael P. Schön pages 509-514 Abstract | Full Text | Full-Text PDF (150 KB)
Monitoring biologics for the treatment of psoriasis Kim A. Papp pages 515-521 Abstract | Full Text | Full-Text PDF (139 KB)
Fumaric acid esters Martin Rostami Yazdi, Ulrich Mrowietz pages 522-526 Abstract | Full Text | Full-Text PDF (218 KB)
Targeting leukocyte recruitment in the treatment of psoriasis Yi-Yang Yvonne Li, Thomas M. Zollner, Michael P. Schön pages 527-538 Abstract | Full Text | Full-Text PDF (410 KB)
Chemokines and other mediators as therapeutic targets in psoriasis vulgaris Bernhard Homey, Stephan Meller pages 539-545 Abstract | Full Text | Full-Text PDF (210 KB)
Nonstandard and off-label therapies for psoriasis Caroline P. Halverstam, Mark Lebwohl pages 546-553 Abstract | Full Text | Full-Text PDF (175 KB)
Future perspectives/quo vadis psoriasis treatment? Immunology, pharmacogenomics, and epidemiology Alexa B. Kimball, Thomas S. Kupper pages 554-561 Abstract | Full Text | Full-Text PDF (172 KB)
Contemporary Dermatology
Lawrence Charles Parish pages 563-564 Full Text | Full-Text PDF (312 KB)
Impact of seasonality on conducting clinical studies in dermatology Stefan C. Weiss, Richard Rowell, Lincoln Krochmal pages 565-569 Abstract | Full Text | Full-Text PDF (597 KB)
Self-experimenters in medicine: heroes or fools? Part I. Pathogens Paul T. Martinelli, Adam Czelusta, S. Ray Peterson pages 570-573 Full Text | Full-Text PDF (114 KB)
Freedom for the Bulgarian nurses and a Palestinian doctor Lawrence Charles Parish page 574 Full Text | Full-Text PDF (123 KB)
Alan Lyell, MD (Cantab), FRCP (Ed), FRCP (Glas) 4th November 1917 – 2nd November 2007 Thomas McFadyen, Stewart Douglas, On behalf of his friends and former colleagues pages 575-580 Full Text | Full-Text PDF (787 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
